Potassium Channel Antagonists [MoA]: Side Effects & Safety Data for 4 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Potassium Channel Antagonists [MoA] includes 4 drugs with a combined 61,292 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
4
Drugs in Class
61,292
Combined Reports
All Potassium Channel Antagonists [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| DALFAMPRIDINE | Dalfampridine | 56,141 | 1,482 | 7,813 | 2.6% |
| REPAGLINIDE | Repaglinide | 2,544 | 169 | 1,517 | 6.6% |
| AMIFAMPRIDINE | Firdapse | 2,424 | 203 | 680 | 8.4% |
| NATEGLINIDE | Nateglinide | 183 | 19 | 51 | 10.4% |
Common Side Effects in Potassium Channel Antagonists [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Gait disturbance | 8,902 | 40 |
| Drug ineffective | 7,186 | 31 |
| Fall | 5,824 | 66 |
| Therapy cessation | 4,590 | 28 |
| Fatigue | 3,956 | 39 |
| Balance disorder | 3,827 | 10 |
| Condition aggravated | 3,440 | 55 |
| Multiple sclerosis relapse | 3,322 | 29 |
| Dizziness | 3,124 | 6 |
| Urinary tract infection | 2,823 | 48 |